跳至主要内容
临床试验/CTIS2023-510186-98-00
CTIS2023-510186-98-00进行中(未招募)1 期

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

Academisch Ziekenhuis Leiden0 个研究点目标入组 10,078 人开始时间: 2024年4月29日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
10,078

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Subjects scheduled to undergo an elective Total Hip Arthroplasty or Total Knee Arthroplasty, Subjects aged 18 years or older

排除标准

  • Primary arthroplasty for fractures, Patients using thrombocyte aggregation inhibitors that cannot be temporarily discontinued at the discretion of their treating physician, Revision surgery, Hemiarthroplasty, Pregnancy, Current use of therapeutic anticoagulant therapy of any type (e.g., LMWH, DOAC, vitamin K antagonist), A contraindication for either study drug, Insufficient knowledge of the Dutch language, Insufficient mental or physical ability to fulfil trial requirements, Active malignancy (i.e. cancer diagnosis within six months before surgery (excluding basal-cell or squamous-cell carcinoma of the skin), recently recurrent or progressive cancer or any cancer that required anti-cancer treatment within six months before surgery)

研究者

相似试验

DISTINCT: inDividual, targeted thrombosIS... | 临床试验